Harjus Birk
Neurology · Palo Cedro, CANPI 1275064396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,285, more than ten times the $20 reported in 2019.
Across 98 payments — averaging $25.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$386
- UCB, Inc.$367
- AstraZeneca$323
- AbbVie$187
- SK Life Science, Inc.$177
- Takeda Pharmaceuticals U.S.A., Inc.$174
- plus $858 from 22 others
What the payments were for
- Speaking & faculty fees$452%
- Food & beverage$2,42798%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 16 | $386 |
| UCB, Inc. | 14 | $367 |
| AstraZeneca(2 entities) | 11 | $323 |
| AbbVie | 7 | $187 |
| SK Life Science, Inc. | 6 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $174 |
| Neurocrine Biosciences, Inc. | 5 | $110 |
| Genentech USA, Inc. | 4 | $93 |
| Sanofi | 3 | $88 |
| Teva Pharmaceuticals USA, Inc. | 2 | $65 |
| Amgen | 3 | $57 |
| Acadia Pharmaceuticals Inc | 2 | $48 |
| BD | 1 | $45 |
| Biogen | 2 | $44 |
| Johnson & Johnson | 2 | $37 |
| Argenx US, Inc. | 1 | $29 |
| Catalyst Pharmaceuticals, Inc. | 1 | $29 |
| Grifols USA, LLC | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Merz Pharmaceuticals, LLC | 1 | $22 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Neurelis, Inc. | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Adamas Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,472 in reported general payments places this provider in the 60th percentile of 1,996 neurology providers in California.
Other neurology in Palo Cedro
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.